Lisa J. Caproni

Hampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Modifying non-coding regions of linear DNA vaccines to explore the interplay of expression and inflammation in immunogenicity.

Modifying non-coding regions of linear DNA vaccines to explore the interplay of expression and inflammation in immunogenicity.

Journal: Human vaccines & immunotherapeutics

Published: January 20, 2025

Vector-Free Deep Tissue Targeting of DNA/RNA Therapeutics via Single Capacitive Discharge Conductivity-Clamped Gene Electrotransfer.

Vector-Free Deep Tissue Targeting of DNA/RNA Therapeutics via Single Capacitive Discharge Conductivity-Clamped Gene Electrotransfer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 13, 2024

Optimizing a linear 'Doggybone' DNA vaccine for influenza virus through the incorporation of DNA targeting sequences and neuraminidase antigen.

Optimizing a linear 'Doggybone' DNA vaccine for influenza virus through the incorporation of DNA targeting sequences and neuraminidase antigen.

Journal: Discovery immunology

Published: September 13, 2023

SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model.

SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model.

Journal: Vaccines

Published: May 24, 2022

Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors.

Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors.

Journal: Molecular therapy. Methods & clinical development

Published: July 23, 2021

CAR T Cell Generation by piggyBac Transposition from Linear Doggybone DNA Vectors Requires Transposon DNA-Flanking Regions.

CAR T Cell Generation by piggyBac Transposition from Linear Doggybone DNA Vectors Requires Transposon DNA-Flanking Regions.

Journal: Molecular therapy. Methods & clinical development

Published: October 09, 2019

Production of lentiviral vectors using novel, enzymatically produced, linear DNA.

Production of lentiviral vectors using novel, enzymatically produced, linear DNA.

Journal: Gene therapy

Published: October 17, 2018

Airway T cells protect against RSV infection in the absence of antibody.

Airway T cells protect against RSV infection in the absence of antibody.

Journal: Mucosal immunology

Published: August 31, 2017

Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model.

Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model.

Journal: Cancer immunology, immunotherapy : CII

Published: March 22, 2017

Airway T cells protect against RSV infection in the absence of antibody.

Airway T cells protect against RSV infection in the absence of antibody.

Journal: Mucosal immunology

Published: August 12, 2016

Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice.

Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice.

Journal: Human vaccines & immunotherapeutics

Published: June 20, 2015

A Comparison of Red Fluorescent Proteins to Model DNA Vaccine Expression by Whole Animal In Vivo Imaging.

A Comparison of Red Fluorescent Proteins to Model DNA Vaccine Expression by Whole Animal In Vivo Imaging.

Journal: PloS one

Published: February 16, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026